METHODS FOR THE TREATMENT OF TUMORS

The present invention is directed to methods of treating a tumor, in particular human tumors, including administering an effective amount of a MER tyrosine kinase inhibitor (MER TKI) to inhibit TKI signaling in a tumor. The use of a MER TKI in combination with a chemotherapeutic agent, wherein the M...

Full description

Saved in:
Bibliographic Details
Main Authors WANG Xiaodong, FRYE Stephen V, EARP, III H. Shelton, GRAHAM Douglas Kim
Format Patent
LanguageEnglish
Published 20.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to methods of treating a tumor, in particular human tumors, including administering an effective amount of a MER tyrosine kinase inhibitor (MER TKI) to inhibit TKI signaling in a tumor. The use of a MER TKI in combination with a chemotherapeutic agent, wherein the MER TKI can be administered to a host with a cancer prior to, during, or after administration with a chemotherapeutic agent, provides for increased anti-tumor effects without an increase in the standard of care dosage of the chemotherapeutic agent.
Bibliography:Application Number: US201515301893